Philipe de Souto Barreto, Gérontopôle de Toulouse, Institut du Vieillissement, 37 Allées Jules Guesde, 31000 Toulouse, France, +33 561 145 636,
J Frailty Aging. 2022;11(2):129-134. doi: 10.14283/jfa.2022.14.
Appetite loss/anorexia of aging is a highly prevalent and burdensome geriatric syndrome that strongly impairs the quality of life of older adults. Loss of appetite is associated with several clinical conditions, including comorbidities and other geriatric syndromes, such as frailty. Despite its importance, appetite loss has been under-evaluated and, consequently, under-diagnosed and under-treated in routine clinical care. The International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force met virtually on September 27th 2021 to debate issues related to appetite loss/anorexia of aging. In particular, topics related to the implementation and management of appetite loss in at-risk older adult populations, energy balance during aging, and the design of future clinical trials on this topic were discussed. Future actions in this field should focus on the systematic assessment of appetite in the care pathway of older people, such as the Integrated Care for Older People (ICOPE) program recommended by the World Health Organization. Moreover, clinical care should move from the assessment to the treatment of appetite loss/anorexia. Researchers continue to pursue their efforts to find out effective pharmacologic and non-pharmacologic interventions with a favorable risk/benefit ratio.
老年食欲减退/厌食是一种普遍且负担沉重的老年综合征,严重影响老年人的生活质量。食欲不振与多种临床情况有关,包括合并症和其他老年综合征,如衰弱。尽管其重要性,食欲减退在常规临床护理中评估不足,因此诊断不足和治疗不足。国际衰弱和肌少症研究会议(ICFSR)工作组于 2021 年 9 月 27 日在线举行会议,讨论与老年食欲减退/厌食相关的问题。特别是,讨论了与高危老年人群中食欲减退的实施和管理、衰老过程中的能量平衡以及该主题未来临床试验的设计相关的主题。该领域的未来行动应侧重于系统评估老年人护理途径中的食欲,如世界卫生组织推荐的老年人综合护理(ICOPE)计划。此外,临床护理应从评估转变为治疗食欲减退/厌食。研究人员继续努力寻找具有良好风险/效益比的有效药物和非药物干预措施。